生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Histone deacetylases (HDAC) are a class of enzymes that catalyze the removal of acetyl groups from an amino acid on a histone or a non-histone protein. BRD73954 is a small molecule HDAC inhibitor that exhibits selective and potent inhibitory effects against HDAC6 (IC50 = 0.036 ± 0.018μM) and HDAC8 (IC50 = 0.12 ± 0.064μM). It shows reduced inhibitory potency toward HDAC1, HDAC2, HDAC3, and HDAC7 with IC50 values of 12 ± 2.0, 9.0 ± 6.6, 23 ± 10, and 14 ± 1.7μM, respectively. The IC50 values of BRD73954 for HDAC4, HDAC5, and HDAC9 are over 33μM. Treatment of HeLa cells with BRD73954 (10μM) for 48 hours induced α-tubulin acetylation, but did not affect the acetylation state of H3.[2] | ||
作用机制 | BRD73954 is a small molecule HDAC inhibitor with the most potent inhibitory effect toward HDAC6 and HDAC8. It adopts an optimal binding pose in the catalytic domain of HDAC6, forming key H-bonds with His130, His131, and Tyr302. When docking into HDAC8, BRD73954 achieves optimal chelation geometry and forms key H-bonds with His129 and His130.[2] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.52mL 0.70mL 0.35mL |
17.59mL 3.52mL 1.76mL |
35.17mL 7.03mL 3.52mL |
参考文献 |
---|